Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant plasmid containing human smim25 gene, genetic engineering bacteria, recombinant protein, polyclonal antibody, preparation method and application

A SMIM25, 1.SMIM25 technology, applied in the field of bioengineering, can solve the problems of not many markers, no biological functions, and no peptides yet.

Active Publication Date: 2021-05-07
WEIFANG MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are not many markers for early diagnosis of the disease, and the specificity is not enough, which leads to the fact that some patients are already in the middle and late stages of the disease when they are diagnosed with gastric cancer
In addition, due to tumor recurrence and metastasis, the 5-year survival rate of patients with advanced gastric cancer is less than 30%
[0003] The human SMIM25 gene is a hypothetical gene included in the NCBI database. Bioinformatics analysis shows that the gene encodes a transmembrane protein and belongs to the SMIM protein family, but there is no relevant polypeptide or experimental data related to its biological function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant plasmid containing human smim25 gene, genetic engineering bacteria, recombinant protein, polyclonal antibody, preparation method and application
  • Recombinant plasmid containing human smim25 gene, genetic engineering bacteria, recombinant protein, polyclonal antibody, preparation method and application
  • Recombinant plasmid containing human smim25 gene, genetic engineering bacteria, recombinant protein, polyclonal antibody, preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0050] The present invention also provides a method for preparing the above-mentioned recombinant plasmid, in which a human SMIM25 gene fragment is introduced into the basic plasmid to construct the recombinant plasmid.

[0051] The preparation method of the above-mentioned recombinant plasmid provided by the present invention has simple process, convenient operation, low requirements for technical personnel, strong universality, high success rate of preparing the target recombinant plasmid, and is suitable for actual production.

[0052] Preferably, the basic plasmid is pGEX-4T-1.

[0053] The expression vector contains a tac promoter, which can achieve chemically induced high-level expression; at the same time, it has a GST tag, and the fusion protein can increase the solubility of the target protein; the obtained fusion protein of the target protein is convenient for further processing under mild conditions. Column purification; using anti-GST tagged antibody can be easily ...

Embodiment 1

[0082] Example 1 Prokaryotic expression vector construction and sequencing identification

[0083] 1.1 According to the human SMIM25 cDNA sequence included in GenBank, the whole gene was synthesized, and BamHI and XhoI restriction sites were introduced before the start codon and after the stop codon, respectively.

[0084] 1.2 Construction and identification of cloning vectors

[0085] The pGEX-4T-1 and the synthetic SMIM25 whole gene fragment were double digested with BamHI and XhoI, and the target fragment was recovered. T4 DNA ligase was ligated overnight at 16°C, and the ligated product was transformed into Escherichia coli DH5H5α competent cells. Positive clones were screened with ampicillin (100 μg / ml), plasmids were extracted in small doses by alkaline lysis, and sent to Shanghai GenScript Company for sequencing identification. Sequencing results such as Figure 1A with 1B As shown in -1D, the result shows that the sequencing of the recombinant plasmid provided in th...

Embodiment 2

[0086] Induced expression and identification of embodiment 2 recombinant protein

[0087] Transform the competent cells of the recombinant pGEX-4T-1-SMIM25 with the correct sequence expression strain BL21 (DE3) to induce expression of the fusion protein: inoculate a single colony transformed with the recombinant plasmid (pGEX-4T-1-SMIM25) in 5m1 LB (Amp+) liquid medium, 37°C, 160rpm, shaking culture overnight. The next day, replant in fresh LB (Amp+) liquid medium at a ratio of 1:100, culture at 37°C, 220rpm for 3h until the OD600 is about 0.6, add IPTG to a final concentration of 1mM, continue to culture for 5h, and induce Expression of SMIM25 recombinant fusion protein. The culture products were collected, the culture medium and the bacteria were separated, the supernatant and the precipitate were separated after the bacteria were ultrasonically disrupted, and the presence or absence of fusion expression of the target protein and the distribution of the protein were analyze...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a recombinant plasmid containing human SMIM25 gene, a genetically engineered bacteria, a recombinant protein, a polyclonal antibody, a preparation method and application thereof, and relates to the technical field of bioengineering. The present invention provides a recombinant plasmid containing human SMIM25 gene fragment. The plasmid has low production cost and can be induced to produce a recombinant fusion protein in Escherichia coli, and the SMIM25 polyclonal antibody can be prepared by using the protein as an antigen to rapidly and accurately detect the SMIM25 protein, thereby assisting in the diagnosis of gastric cancer. The SMIM25 recombinant fusion protein provided by the present invention can be used as an antigen to carry out relevant immunological experiments. The SMIM25 recombinant fusion protein is used as an immunogen and mixed with adjuvant and injected into rabbits. The polyclonal antibody obtained after protein purification can bind to the prokaryotic expression protein and the SMIM25 protein in human cells, so it can be used to further study the specificity of the SMIM25 gene. Function.

Description

technical field [0001] The invention relates to the technical field of bioengineering, in particular to a recombinant plasmid containing human SMIM25 gene, genetic engineering bacteria, recombinant protein, polyclonal antibody, preparation method and application. Background technique [0002] Malignant tumors have always been one of the major diseases faced by countries all over the world. Gastric cancer is one of them, and it is also one of the malignant tumors with the highest mortality rate in China. At present, there are not many markers for early diagnosis of the disease, and the specificity is not enough, which leads to the fact that some patients are already in the middle and late stage of the disease when they are diagnosed with gastric cancer. In addition, due to tumor recurrence and metastasis, the 5-year survival rate of patients with advanced gastric cancer is less than 30%. Therefore, further exploration of the molecular mechanism of gastric cancer proliferatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/70C12N1/21C07K19/00C07K16/18G01N33/574
CPCC07K14/47C07K16/18C07K2319/21C07K2319/23C07K2319/41C07K2319/42C12N15/70G01N33/57446
Inventor 林志娟梁淑娟付晓燕秦浩
Owner WEIFANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com